1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32 | Medication Error.
During the investigative process, five staff persons were interviewed. An attempted interview was made with the resident (Resident 1); however, he did not engage in conversation. A walk-through of the facility was conducted whereas residents’ well-being was observed, and several records were reviewed. Various documents were obtained and reviewed to include Physicians Report, Admission Agreement, Appraisal and Needs, Medication Administration Records (MARs), Incident Reports, and a list of staff names.
On 04/29/22, the licensing agency received a copy of resident’s (Resident 1) Medication Administration Records (MARs), (21 pages). Upon review of the MARs, it was noted that several medications were discontinued during the months of December/January 2021. Medications include Aripiprazole, 2mg; Risperidone, 1mg; and Sertraline, 50mg. During the months of February/March 2022, medication was discontinued to include Levetiracetam, 500mg. The staff did not have a prescription order in place, as required to discontinue the medications; but rather received a verbal order.
Based on LPAs observations and interviews which were conducted and record review(s), the preponderance of evidence standard has been met, therefore the above allegation(s) is found to be Substantiated. California Code of Regulations, (Title 22), is being cited on the attached LIC 9099D.
Appeal Rights were explained and provided to the facility representative listed above and an exit interview was conducted. If any of the cited deficiencies are not corrected by the noted due dates; civil penalties may be assessed.
continued |